Since transcripts marked with m6A in control neuroblastoma cells showed increased expression in cells treated with STM2457, we hypothesized that the reduction of m6A RNA deposition resulting from METTL3/14 inhibition would enhance the stability of these transcripts. Here, METTL3 is linked to neuroblastoma.